Introduction: Mesenchymal stem cells can potentially be used in therapy for spinal cord injury (SCI). Methylprednisolone sodium succinate (MPSS) has been used as a scavenging agent in acute SCI treatment, but its use no longer recommended. This study aimed to identify ways to reduce the usage and risk of high doses of glucocorticoid steroids, and determine whether AD-MSCs could be used as an early alternative treatment modality for acute SCI.Methods: Sixteen adult beagle dogs with SCI were assigned to four treatment groups: control, MPSS, AD-MSCs, and AD-MSCs + MPSS. Additionally, one dog was used to evaluate the distribution of AD-MSCs in the body after injection. AD-MSCs (1 × 107cells) were injected intravenously once a day for 3 days beginning at 6 hours post-SCI. MPSS was also injected intravenously according to the standard protocol for acute SCI. A revised Tarlov scale was used to evaluate hindlimb functional recovery. The levels of markers for oxidative metabolism (3-nitrotyrosine, 4-hydroxynonenal, and protein carbonyl) and inflammation (cyclooxygenase-2, interleukin-6, and tumor necrosis factor-α) were also measured.Results: At 7 days post-treatment, hindlimb movement had improved in the AD-MSCs and AD-MSCs + MPSS groups; however, subjects in the groups treated with MPSS exhibited gastrointestinal hemorrhages. Hematoxylin and eosin staining revealed fewer hemorrhages and lesser microglial infiltration in the AD-MSCs group. The green fluorescent protein-expressing AD-MSCs were clearly detected in the lung, spleen, and injured spinal cord; however, these cells were not detected in the liver and un-injured spinal cord. Levels of 3-nitrotyrosine were decreased in the MPSS and AD-MSCs + MPSS groups; 4-hydroxynenonal and cyclooxygenase-2 levels were decreased in all treatment groups; and interleukin-6, tumor necrosis factor-α, and phosphorylated-signal transducer and activator transcription 3 levels were decreased in the AD-MSCs and AD-MSCs + MPSS groups.Conclusion: Our results suggest that early intravenous injection of AD-MSCs after acute SCI may prevent further damage through enhancement of antioxidative and anti-inflammatory mechanisms, without inducing adverse effects. Additionally, this treatment could also be used as an alternative intravenous treatment modality for acute SCI.
The aim of this study was to investigate the in vitro osteogenic capacity of bone morphogenetic protein 7 (BMP-7) overexpressing adipose-derived (Ad-) mesenchymal stem cells (MSCs) sheets (BMP-7-CS). In addition, BMP-7-CS were transplanted into critical-sized bone defects and osteogenesis was assessed. BMP-7 gene expressing lentivirus particles were transduced into Ad-MSCs. BMP-7, at the mRNA and protein level, was up-regulated in BMP-7-MSCs compared to expression in Ad-MSCs. Osteogenic and vascular-related gene expressions were up-regulated in BMP-7-CS compared to Ad-MSCs and Ad-MSC sheets. In a segmental bone-defect model, newly formed bone and neovascularization were enhanced with BMP-7-CS, or with a combination of BMP-7-CS and demineralized bone matrix (DBM), compared to those in control groups. These results demonstrate that lentiviral-mediated gene transfer of BMP-7 into Ad-MSCs allows for stable BMP-7 production. BMP-7-CS displayed higher osteogenic capacity than Ad-MSCs and Ad-MSC sheets. In addition, BMP-7-CS combined with demineralized bone matrix (DBM) stimulated new bone and blood vessel formation in a canine critical-sized bone defect. The BMP-7-CS not only provides BMP-7 producing MSCs but also produce osteogenic and vascular trophic factors. Thus, BMP-7-CS and DBM have therapeutic potential for the treatment of critical-sized bone defects and could be used to further enhance clinical outcomes during bone-defect treatment.
Objective: This study aimed to describe the technique and evaluate the clinical outcomes of utilizing a biportal endoscopic spine surgery (BESS) for the treatment of thoracolumbar intervertebral disc herniation (IVDH) in dogs.Methods: Thirteen client-owned dogs diagnosed with single level thoracolumbar IVDH using magnetic resonance imaging were included. A mini-hemilaminectomy was performed using the BESS system. Briefly, the dogs were positioned in sternal recumbency and two portal skin entry points were confirmed under fluoroscopic guidance. The endoscopic portal provided continuous irrigation and visualization, while the instrumental portal allowed for instrument manipulation and disc removal. Pre- and postoperative neurologic status, operation time, perioperative complications were recorded and analyzed.Results: The dogs ranged in age from 4 to 11 years (median 7.5 years) and weighed ranging from 5.0 to 9.1 kg (median 7.4 kg). Clinical presentations ranged from ambulatory paraparesis to non-ambulatory paraparesis. The BESS approach enabled effective spinal cord decompression and removal of extruded disc material without intraoperative complications. No cases required conversion to open hemilaminectomy. The average operation time was 53 ± 10.5 min. At 6 weeks postoperatively, all dogs exhibited normal neurological function, and no complications were reported.Conclusion: These clinical findings support that minimally invasive BESS is a safe and feasible technique for treating thoracolumbar IVDH in small-breed dogs. The BESS approach offers an effective surgical alternative for the treatment of thoracolumbar IVDH in canine patients.
1 February 2025 in American Journal of Veterinary Research
OBJECTIVE: This study aimed to compare the accuracy of brain biopsies in skull-brain tumor models (SBTMs) of dogs and cats using 2 techniques: 3-D–printed brain biopsy guides (3D-BBGs) and electromagnetic (EM) neuronavigation. METHODS: Based on the CT data from 12 dogs and 3 cats, a total of 30 SBTMs were created using 3-D–printing technology, with 2 models per data set. Thirty brain biopsies were performed: 15 using 3D-BBGs and 15 using EM neuronavigation. The accuracy of the brain biopsies was assessed by comparing the prebiopsy and postbiopsy models using computer-aided design software. RESULTS: The median needle placement error for all biopsies was 1.75 mm (range: 0.82 to 3.16 mm), with 1.79 mm (range: 0.94 to 2.94 mm) for the 3D-BBG group and 1.68 mm (range: 0.82 to 3.16 mm) for the EM neuronavigation group. There was no significant difference in accuracy between the 2 methods. In the EM neuronavigation group, the needle placement error correlated significantly with the total needle length, but no such correlation was observed in the 3D-BBG group. Both methods successfully retrieved samples from brain tumor models. CONCLUSIONS: There was no significant difference in the accuracy of brain biopsies performed using 3D-BBGs and EM neuronavigation. This suggests that the choice of method depends on veterinarian preference, available hospital resources, and patient-specific considerations. CLINICAL RELEVANCE: This study demonstrates that both 3D-BBG and EM neuronavigation are viable options for performing brain biopsies in veterinary practice, potentially improving the diagnosis and treatment of brain tumors in small animals.
5 September 2022 in Veterinary Radiology & Ultrasound
Objectives: To describe the clinical characteristics of 11 dogs and 2 cats with extrahepatic biliary obstruction (EHBO) who underwent self‐expandable metal stent (SEMS) placement. We also examined the indications for the procedure and evaluated its outcomes. Lastly, we identified risk factors associated with survival in these animals.Methods: This retrospective study included 11 client‐owned dogs and 2 client‐owned cats that underwent biliary SEMS placement. Medical records were reviewed.Results: The average age of the animals was 9.3 years (range, 6–15). The majority of animals had at least one clinical sign associated with EHBO. Frequently appearing clinical signs were inappetence, lethargy and jaundice. No complications were found related to the stenting procedure. Clinical signs and serum total bilirubin concentration improved postoperatively in all 13 animals. The 12 animals (92.3%) that survived until discharge were followed up to 2 years postoperatively, during which time no significant complications were observed.Clinical significance: Biliary SEMS placement may be considered as a treatment option for dogs and cats with EHBO, with minor complications and potential for permanent treatment of EHBO.